PHARMAQ Analytiq
PHARMAQ Analytiq, part of Zoetis-owned PHARMAQ, is a specialised aquaculture diagnostics provider delivering PCR, histopathology (with ML gill scoring), SmoltVision, microbiology, and NGS services to enterprise salmonid, tilapia, pangasius, sea-bass, and cleaner-fish farmers from laboratories across Norway, Scotland, Ireland, and Chile.
- Company typePrivate
- Founded1986
- HeadquartersØysletta, Norway
- Headcount11–50
- GTM typeB2B
- OfferingServices
What PHARMAQ Analytiq does
PHARMAQ Analytiq is the diagnostic-services arm of PHARMAQ, a wholly-owned business unit of Zoetis (NYSE: ZTS), providing fish-health analysis and advice to the global aquaculture industry. Operating since the 2020 acquisition of Fish Vet Group and rebranded to PHARMAQ Analytiq in May 2021, the division runs specialised laboratories in Norway (Bergen headquarters, Oslo, Rørvik), Scotland (Inverness), Ireland (Galway), and Chile (Puerto Montt), with field sales tied to a parent distribution network spanning Norway, Chile, the UK, Vietnam, Turkey, Spain, Panama, and Hong Kong.
The unit's commercial offer is anchored by seven core diagnostic modalities—Real-time RT-PCR, Histopathology (with a digital-pathology platform and machine-learning gill-health scoring), SmoltVision (ATPase-based smoltification analysis), Microbiology, Next-Generation Sequencing, Data Analytics, and Consultancy & Training—delivered alongside the iWISE customer portal. Technology is substantively proprietary: 17 veterinary pathologists (including 3 ECVP Diplomates and 8 PhDs) staff the histopathology service, machine-learning models generate continuous 0–100% gill-health scores from tissue images, and NGS pipelines enable whole-genome pathogen characterisation. Customers span salmonid (Norway, Scotland, Chile), tilapia (Sub-Saharan Africa via A.L.P.H.A. Plus), pangasius (Vietnam Mekong Delta), sea bass (Mediterranean), and cleaner-fish aquaculture, with a 2024 Sub-Saharan Africa programme co-funded by a USD 15.3M Gates Foundation grant.
Revenue is generated through professional-services fees for laboratory analysis, hardware and consumable sales for vaccination equipment (Micro-Matic syringes, NFT machines), and one-time sales of the ALPHA JECT vaccine portfolio; pricing is quote-based via regional sales managers rather than publicly listed. Quote-based B2B economics, an enterprise customer base (Norwegian/Scottish/Chilean salmon farmers, pangasius and tilapia producers), and multi-decade contracts with major farming groups imply high customer lifetime value but limited churn flexibility. Distribution leverages direct enterprise sales plus parent-company (Zoetis) channels, with CHANNEL partners and a self-serve iWISE layer for mid-market accounts.
PHARMAQ Analytiq firmographics
Firmographics- Name
- PHARMAQ Analytiq
- Legal name
- PHARMAQ AS
- Website
- https://pharmaq.com
- Company type
- Private
- Founded year
- 1986
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- PHARMAQ Analytiq, part of Zoetis-owned PHARMAQ, is a specialised aquaculture diagnostics provider delivering PCR, histopathology (with ML gill scoring), SmoltVision, microbiology, and NGS services to enterprise salmonid, tilapia, pangasius, sea-bass, and cleaner-fish farmers from laboratories across Norway, Scotland, Ireland, and Chile.
- Ownership category
- akta.pro rank
PHARMAQ Analytiq industry classification
Industry- Product category
- Aquaculture Diagnostics and Health Services
- NAICS
- Aquaculture (11251), Pharmaceutical Preparation Manufacturing (325412), Veterinary Services (54194)
- SIC
- Services-Medical Laboratories (8071), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Aquaculture & Fish Health Services (AFAEANAE)
- akta.pro secondary industries
- Veterinary Pharmacy, Vaccine & Biologics Services (AFAEANAK), Veterinary EMR/EHR & Clinical Workflow (HLAMAMAB)
Keywords
Where PHARMAQ Analytiq is headquartered
LocationHeadquarters
- HQ city
- Øysletta
- HQ country
- Norway
- HQ region
- Europe
Offices11 records
Markets served
PHARMAQ Analytiq business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Fish Vaccines and Therapeutics: Sale of pharmaceutical products including injectable vaccines (ALPHA JECT product line), immersion vaccines, immunostimulants, therapeutics, and biocides for fish health
- Diagnostic Services: Laboratory analysis services including RT-PCR, histopathology, microbiology, SmoltVision analysis, NGS, and data analytics for fish health monitoring
- Vaccination Equipment: Sale of vaccination machinery and equipment through PHARMAQ Fishteq division including Micro-Matic syringes and NFT machines
- Training and Consultancy: Fish health consulting services and training programs including PHARMAQademy educational events
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
PHARMAQ Analytiq product offering
Product offeringCore offering
PHARMAQ Analytiq provides fish health diagnostics, laboratory analysis, and advisory services to the global aquaculture industry. As part of PHARMAQ (a Zoetis company), it offers Real-time RT-PCR, histopathology, microbiology, Next Generation Sequencing, SmoltVision smoltification analysis, and data analytics delivered through a global network of veterinary pathologists and laboratories. The division also encompasses PHARMAQ's vaccines (ALPHA JECT line) and PHARMAQ Fishteq vaccination equipment (NFT machines, Micro-Matic syringes).
Product overview
PHARMAQ Analytiq operates as part of PHARMAQ, a Zoetis company, offering a comprehensive aquaculture health portfolio. The company provides three core product lines: PHARMAQ (vaccines and therapeutics including the ALPHA JECT micro vaccine family), PHARMAQ Fishteq (vaccination equipment including NFT machines and Micro-Matic syringes), and PHARMAQ Analytiq (diagnostics and advisory services). The Analytiq division delivers diagnostic services including Real-time RT-PCR, Histopathology (with digital pathology and machine learning), SmoltVision, Microbiology, NGS (Next Generation Sequencing), Data Analytics, and Consultancy and Training. The company acquired Fish Vet Group in 2020 and rebranded it under the Analytiq name in 2021, creating one of the world's largest aquaculture diagnostic providers with operations in Norway, Scotland, Ireland, and Chile. Digital services are delivered through the iWISE customer portal.
Differentiator
Problem solved
Functional benefit
Brands
- Fish Vet Group: Aquaculture diagnostic services provider acquired by Zoetis in 2020 and rebranded to PHARMAQ Analytiq in 2021. Provided veterinary services, bacteriology, histology, PCR testing, and environmental monitoring.
- ALPHA JECT
- iWISE
- SmoltVision
Products and services
- PHARMAQ Vaccines and Therapeutics Vaccines, immunostimulants, therapeutic products, and biocidal products for fish disease prevention and treatment across salmon, tilapia, pangasius, sea bass, and cleaner fish species. Includes the ALPHA JECT micro series and other multivalent vaccine formulations.
- PHARMAQ Fishteq Vaccination Equipment Vaccination machinery and equipment including NFT machines and Micro-Matic syringes, plus associated vaccination services for aquaculture operations.
- PHARMAQ Analytiq Diagnostics and Advice Comprehensive fish health diagnostic services and advisory through veterinary pathologists, covering molecular diagnostics, histopathology, microbiology, next-generation sequencing, smoltification monitoring, and data analytics.
- Real-time RT-PCR Molecular diagnostic testing for rapid, specific detection of viral and bacterial pathogens in fish, providing yes/no answers on presence of infectious agents in samples.
- Histopathology Tissue examination at cellular level performed by veterinary pathologists, including digital pathology platform for high-resolution image analysis, gill scoring, and heart scoring methods. Team of 17 pathologists globally with European/American specialization.
- SmoltVision Analysis of freshwater and seawater ATPase levels to assess smoltification readiness at individual and group level, supporting optimal sea transfer timing decisions.
- Microbiology Modern microbiology laboratory for analysis and identification of fish disease bacteria, including classical microbiology, molecular methods, antimicrobial susceptibility testing, and water and environmental monitoring for RAS and flow-through systems.
- Next Generation Sequencing (NGS) Advanced sequencing-based diagnostic service including microbiome profiling in RAS and flow-through systems, pathogen identification and characterization, full genome sequencing of viruses and bacteria, and molecular tracing of infection pathways.
- Data Analytics Predictive analytics combining laboratory data with production data to model disease probability and classify farm conditions, delivered through intuitive dashboards and pilot studies.
- Consultancy and Training Fish health consulting services and professional training for aquaculture operators on sampling techniques, diagnostics interpretation, and health management, including PHARMAQademy educational events.
- iWISE Customer Portal Digital customer portal for laboratory order registration, sample submission, and report delivery, providing secure access to results, sampling videos, and service information.
- Customer Projects Custom research and development projects including grant application assistance, protocol design, development of tailored analyses, and histopathological scoring methods. Collaboration on FHF and NFR publicly funded projects.
Quantifiable outcome
- 99.8% reduction in antibiotics use per ton of produced salmon compared to 1987 levels in Norwegian aquaculture
- +4 more outcomes
Companies that use PHARMAQ Analytiq
Customer profileNamed customers4 records
Segments5 records
Ideal customer profiles4 records
PHARMAQ Analytiq technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability8 records
Feature8 records
PHARMAQ Analytiq partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- SýnicoreStrategic partnership with Iceland's leading privately owned laboratory to establish advanced diagnostic service for aquaculture industry in Iceland. Service launches Q1 2026. Combines Sýni's local expertise and food safety capabilities with PHARMAQ Analytiq's specialization in fish health and diagnostics.
- Norwegian University of Life Sciences (NMBU)coreStrategic partnership for disease surveillance in tilapia farms across Sub-Saharan Africa. Part of A.L.P.H.A. Plus initiative funded by Zoetis and Bill & Melinda Gates Foundation. Led by Professors Øystein Evensen and Stephen Mutoloki to understand fish health needs of tilapia producers.
- Fish Vet GroupcoreAcquired by Zoetis in July 2020 as strategic addition to PHARMAQ. Fish Vet Group was part of Benchmark Holdings, PLC. Merger created world-leading full-service supplier with doubled histopathology capacity. Headquarters in Inverness, Scotland with additional labs in Norway, Ireland, and Chile. Renamed to PHARMAQ Analytiq in 2021.
- ZoetiscorePHARMAQ was acquired by Zoetis in 2015. PHARMAQ operates as a business unit within Zoetis, the world leader in animal health. Zoetis has approximately 10,000+ employees and generated revenue of $6.3 billion in 2019.
- ONDAminorPartnership with ONDA (Oceanography and Marine Research) to carry out ISAV vaccination trial in Atlantic Canada. Comparing efficacy of ALPHA JECT micro 7 ISA vaccine against North American and European ISAV strains.
- Royal Veterinary College (RVC), LondonminorResearch partnership for whole genome sequencing of fish viruses (PMCV causing CMS and ILA virus). Project initiated by PHARMAQ, led by Dr. Sarah Hill at RVC, fully funded by UK Biotechnology and Biological Science Research Council (BBSRC). PHARMAQ contributes virus samples and supplementary information.
Scale indicators14 records
Recent moves6 records
Expansion highlights6 records
PHARMAQ Analytiq competitors and assessment
Company assessmentMarket position
Competitive moat6 records
Key risks5 records
Key highlights6 records
Customer concentration
PHARMAQ Analytiq social profiles
Digital presencePHARMAQ Analytiq financial estimates
Financial estimateRevenue estimate
Valuation estimate
PHARMAQ Analytiq leadership team
Management profileNumber of profiles
Profiles6 records
PHARMAQ Analytiq subsidiaries and ownership
Company hierarchySubsidiaries8 records
PHARMAQ Analytiq funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PHARMAQ Analytiq M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PHARMAQ Analytiq
What does PHARMAQ Analytiq do?
PHARMAQ Analytiq provides fish health diagnostics, laboratory analysis, and advisory services to the global aquaculture industry. As part of PHARMAQ (a Zoetis company), it offers Real-time RT-PCR, histopathology, microbiology, Next Generation Sequencing, SmoltVision smoltification analysis, and data analytics delivered through a global network of veterinary pathologists and laboratories. The division also encompasses PHARMAQ's vaccines (ALPHA JECT line) and PHARMAQ Fishteq vaccination equipment (NFT machines, Micro-Matic syringes).
Is PHARMAQ Analytiq a public or private company?
PHARMAQ Analytiq is a private company. It is classified as corporate owned and is currently operating.
When was PHARMAQ Analytiq founded?
PHARMAQ Analytiq was founded in 1986. It employs 11 to 50 people.
Where is PHARMAQ Analytiq based?
PHARMAQ Analytiq is headquartered in Øysletta, Norway, in the Europe region.
How does PHARMAQ Analytiq make money?
Four revenue lines are on record. Fish Vaccines and Therapeutics are the primary driver. The others are diagnostic Services, vaccination Equipment and training and Consultancy.
Does PHARMAQ Analytiq have an API?
No public API is recorded for PHARMAQ Analytiq.
What industry is PHARMAQ Analytiq in?
PHARMAQ Analytiq's product category is Aquaculture Diagnostics and Health Services. Its primary akta.pro industry code is AFAEANAE, Aquaculture & Fish Health Services, with a secondary code of AFAEANAK, Veterinary Pharmacy, Vaccine & Biologics Services. Its NAICS code is 11251 and its SIC code is 8071.